{"id":1819,"date":"2019-09-25T22:22:24","date_gmt":"2019-09-25T20:22:24","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=1819"},"modified":"2025-01-27T08:56:43","modified_gmt":"2025-01-27T07:56:43","slug":"radiobiology-cancer-2","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/radiobiology-cancer-2\/","title":{"rendered":"Radiobiology & Cancer"},"content":{"rendered":"\n

\n\t\tRadiobiology & cancer\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\t

The Radiobiology and Cancer group, led by Ferran Guedea, works on the translational aspect of integrating radiobiological findings into clinical patient outcome parameters and clinical studies<\/p>\n

514<\/h2>\n

Publications<\/h2>\n\t\t\t\t\"113-radiobiologiacancer-guedea-def\"\n\t\t\t\t\tStrategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\tStudy on:
\n1. How high doses of radiotherapy (SBRT, IORT and HDR) could trigger immune stimulation through modulation of cytokines and immune cells in plasma.
\n2. Predictive radiation sensitivity tests.
\n3. New therapeutic strategies in brachytherapy.
\n4. New therapeutic strategies in external radiotherapy.
\n5. Evaluation of quality of life in the treatment of prostate cancer.
\n6. Application of intracranial stereotactic radiotherapy (SRT) and
\n7. Stereotactic body radiotherapy (SBRT) techniques.\n\t\t\t\t\t
Selected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t